04/01/2015 - 11:03am

Diplomat Pharmacy raised almost $200 million in follow-on public offering that closed Tuesday. 

04/01/2015 - 10:54am

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

03/30/2015 - 10:50am

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.

03/25/2015 - 11:17am

Fred's acquired a specialty pharmacy operation for $66 million.

03/24/2015 - 10:02am

Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.

03/18/2015 - 11:51am

Diplomat Pharmacy to offer PARI’s cystic fibrosis treatment Kitabis Pak together with a PARI LC Plus nebulizer handset.

03/16/2015 - 11:27am

Diplomat Pharmacy is looking to raise $200 million with a proposed follow-on public offering of its common stock.

03/12/2015 - 1:53pm

CVS Health’s chief medical officer Troyen Brennan said in an interview with Reuters that the entry of copycat biotech drugs could cut prices of expensive medications by 40% to 50%.

03/12/2015 - 11:50am

Drug Channels Institute on Thursday listed the leading specialty pharmacy players.